{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:15:09Z","timestamp":1777994109480,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R36 HS022199"],"award-info":[{"award-number":["R36 HS022199"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2P50-CA098252-11"],"award-info":[{"award-number":["2P50-CA098252-11"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA123467"],"award-info":[{"award-number":["R01 CA123467"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10552-017-0976-x","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T05:00:22Z","timestamp":1510203622000},"page":"43-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap\/HPV cotesting in women aged 30\u201365\u00a0years"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4080-7242","authenticated-orcid":false,"given":"Michelle I.","family":"Silver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne F.","family":"Rositch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darcy F.","family":"Phelan-Emrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patti E.","family":"Gravitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"976_CR1","unstructured":"Howlader NNA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA: SEER Cancer Statistics Review, (1975\u20132011), National Cancer Institute. Bethesda, MD, \n                    http:\/\/seer.cancer.gov\/csr\/1975_2011\/\n                    \n                  , based on November 2013 SEER data submission, posted to the SEER web site, April 2014. 2014"},{"key":"976_CR2","volume-title":"behavioral risk factor surveillane system survey data. In. Edited by Services DoHaH","author":"CDC","year":"2012","unstructured":"CDC (2012) behavioral risk factor surveillane system survey data. In. Edited by Services DoHaH. Atlanta: Centers for Disease Control and Prevention"},{"issue":"2","key":"976_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/AOG.0b013e3182253c33","volume":"118","author":"DF Phelan","year":"2011","unstructured":"Phelan DF, Boitnott J, Clark DP, Dubay L, Gravitt P (2011) Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory. Obstetrics Gynecol 118(2):289\u2013295","journal-title":"Obstetrics Gynecol"},{"issue":"2","key":"976_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1309\/AJCPPVX91HQMNYZZ","volume":"138","author":"AD Tatsas","year":"2012","unstructured":"Tatsas AD, Phelan DF, Gravitt PE, Boitnott JK, Clark DP (2012) Practice patterns in cervical cancer screening and human papillomavirus testing. Am J Clin Pathol 138(2):223\u2013229","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"976_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1309\/AJCP41LLYKYUGXVD","volume":"139","author":"JB Bekker","year":"2013","unstructured":"Bekker JB, John TS, Leiman G (2013) Confirming suboptimal adherence to hpv cotesting guidelines in an academic center in Vermont. Am J Clin Pathol 139(2):259\u2013260","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"976_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","volume":"137","author":"D Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FAR, Moriarty AT, Waxman AG, Wilbur DC et al (2012) American cancer society, american society for colposcopy and cervical pathology, and american society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 137(4):516\u2013542","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"976_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","volume":"156","author":"VA Moyer","year":"2012","unstructured":"Moyer VA (2012) Screening for Cervical Cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 156(12):880\u2013891","journal-title":"Ann Intern Med"},{"issue":"5","key":"976_CR8","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","volume":"120","author":"ACOG: Practice Bulletin No. 131","year":"2012","unstructured":"ACOG: Practice Bulletin No. 131 (2012) Screening for cervical cancer. Obstetrics Gynecol 120(5):1222\u20131238","journal-title":"Obstetrics Gynecol"},{"key":"976_CR9","doi-asserted-by":"crossref","unstructured":"Proctor E, Brownson R (2012) Chap. 13: Measurement issues in dissemination and implementation research. Dissemination and implementation research in health: translating science to practice. edn. Edited by Brownson R, Colditz G, Proctor E. New York","DOI":"10.1093\/acprof:oso\/9780199751877.001.0001"},{"key":"976_CR10","first-page":"184188","volume":"139","author":"C Zhao","year":"2014","unstructured":"Zhao C, Li Z, Nayar R, Levi AW, Winkler BA, Moriarty AT, Barkan GA, Rao J, Miller F, Fan F et al (2014) Prior high-risk human papillomavirus testing and papanicolaou test Results of 70 invasive cervical carcinomas Diagnosed in 2012: Results of a Retrospective Multicenter Study. Arch Pathol Lab Med 139:184\u2013188","journal-title":"Arch Pathol Lab Med"},{"key":"976_CR11","doi-asserted-by":"publisher","first-page":"29762983","DOI":"10.1002\/cncr.29445","volume":"121","author":"S Weinmann","year":"2015","unstructured":"Weinmann S, Williams AE, Kamineni A, Buist DSM, Masterson EE, Stout NK, Stark A, Ross TR, Owens CL, Field TS et al (2015) Cervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007. Cancer 121:2976\u20132983","journal-title":"Cancer"},{"key":"976_CR12","first-page":"28542863","volume":"136","author":"J Cuzick","year":"2014","unstructured":"Cuzick J, Myers O, Hunt WC, Saslow D, Castle PE, Kinney W, Waxman A, Robertson M, Wheeler CM, on behalf of the New Mexico HPVPRSC, (2014) Human papillomavirus testing 2007\u20132012: co-testing and triage utilization and impact on subsequent clinical management. Int J Cancer 136:2854\u20132863","journal-title":"Int J Cancer"},{"issue":"2","key":"976_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1467-9566.2011.01411.x","volume":"34","author":"S Hogarth","year":"2012","unstructured":"Hogarth S, Hopkins MM, Rodriguez V (2012) A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA. Sociol Health Illn 34(2):234\u2013250","journal-title":"Sociol Health Illn"},{"issue":"6","key":"976_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","volume":"52","author":"D Saslow","year":"2002","unstructured":"Saslow D, Runowitz C, Solomon D, Moscicki A-B, Smith R, Eyre H, Cohen C (2002) American Cancer Society Guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 52(6):342\u2013362","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"976_CR15","first-page":"417","volume":"102","author":"ACOG","year":"2003","unstructured":"ACOG (2003) ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45., August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol 102(2):417\u2013427","journal-title":"Obstet Gynecol"},{"issue":"2","key":"976_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","volume":"103","author":"TCJ Wright","year":"2004","unstructured":"Wright TCJ, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, Hatch K, Noller KL, Roach N, Runowicz C et al (2004) Interim guidance for the use of human papillomavirus DNA testing as an adjunct to Cervical cytology for screening. Obstetrics Gynecol 103(2):304\u2013309. \n                    https:\/\/doi.org\/10.1097\/1001.AOG.0000109426.0000182624.f0000109428","journal-title":"Obstetrics Gynecol"},{"key":"976_CR17","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1001\/jamainternmed.2014.1368","volume":"174","author":"K Smith-McCune","year":"2014","unstructured":"Smith-McCune K (2014) Choosing a screening method for cervical cancer: papanicolaou testing alone or with human papillomavirus testing. JAMA Internal Med 174:1027\u20131028","journal-title":"JAMA Internal Med"},{"issue":"7","key":"976_CR18","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamainternmed.2014.576","volume":"174","author":"S Feldman","year":"2014","unstructured":"Feldman S (2014) CAn the new cervical cancer screening and management guidelines be simplified? JAMA Internal Med 174(7):1029\u20131030","journal-title":"JAMA Internal Med"},{"key":"976_CR19","volume-title":"Diffusion of innovataions","author":"E Rogers","year":"2003","unstructured":"Rogers E (2003) Diffusion of innovataions, 5th\u00a0edn. The Free Press, New York","edition":"5"},{"key":"976_CR20","doi-asserted-by":"crossref","unstructured":"Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, Poitras NE, Lorey T, Cheung LC, Kinney WK (2014) Reassurance Against future risk of precancer and cancer conferred by a negative human papillomavirus test. J Natl Cancer Inst 106(8)","DOI":"10.1093\/jnci\/dju153"},{"issue":"7","key":"976_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","volume":"12","author":"HA Katki","year":"2011","unstructured":"Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE (2011) Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol 12(7):663\u2013672","journal-title":"Lancet Oncol"},{"key":"976_CR22","doi-asserted-by":"publisher","first-page":"a1754","DOI":"10.1136\/bmj.a1754","volume":"337","author":"J Dillner","year":"2008","unstructured":"Dillner J, Rebolj M, Birembaut P, Petry K-U, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S et al (2008) Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 337:a1754","journal-title":"BMJ"},{"issue":"1","key":"976_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"L Damschroder","year":"2009","unstructured":"Damschroder L, Aron D, Keith R, Kirsh S, Alexander J, Lowery J (2009) Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci 4(1):50","journal-title":"Implement Sci"},{"issue":"11","key":"976_CR24","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/ijc.29996","volume":"138","author":"CS Sheppard","year":"2016","unstructured":"Sheppard CS, El-Zein M, Ramanakumar AV, Ferenczy A, Franco EL (2016) Assessment of mediators of racial disparities in cervical cancer survival in the United States. Int J Cancer 138(11):2622\u20132630","journal-title":"Int J Cancer"},{"issue":"2","key":"976_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ygyno.2013.12.039","volume":"133","author":"Y Collins","year":"2014","unstructured":"Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH (2014) Gynecologic cancer disparities: a report from the health disparities taskforce of the society of gynecologic oncology. Gynecol Oncol 133(2):353\u2013361","journal-title":"Gynecol Oncol"},{"key":"976_CR26","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/cncr.30507","volume":"123","author":"AL Beavis","year":"2017","unstructured":"Beavis AL, Gravitt PE, Rositch AF (2017) Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer 123:1044\u20131050","journal-title":"Cancer"},{"issue":"13","key":"976_CR27","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/cncr.28548","volume":"120","author":"AF Rositch","year":"2014","unstructured":"Rositch AF, Nowak RG, Gravitt PE (2014) Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer 120(13):2032\u20132038","journal-title":"Cancer"},{"issue":"5","key":"976_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1158\/1055-9965.EPI-13-0973","volume":"23","author":"J Cuzick","year":"2014","unstructured":"Cuzick J, Myers O, Hunt WC, Robertson M, Joste NE, Castle PE, Benard VB, Wheeler CM (2014) A Population-based evaluation of cervical screening in the United States: 2008\u20132011. Cancer Epidemiol Biomark Prevent 23(5):765\u2013773","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"7","key":"976_CR29","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/ijc.29143","volume":"136","author":"JC Gage","year":"2015","unstructured":"Gage JC, Katki HA, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Castle PE, Kinney WK (2015) Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection. Int J Cancer 136(7):1665\u20131671","journal-title":"Int J Cancer"},{"issue":"5","key":"976_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ajog.2011.06.001","volume":"205","author":"KB Roland","year":"2011","unstructured":"Roland KB, Soman A, Benard VB, Saraiya M (2011) Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States. Am J Obstet Gynecol 205(5):447. \n                    https:\/\/doi.org\/10.1016\/j.ajog.2011.06.001","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"976_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/archinternmed.2010.134","volume":"170","author":"M Saraiya","year":"2010","unstructured":"Saraiya M, Berkowitz Z, Yabroff KR, Wideroff L, Kobrin S, Benard V (2010) Cervical cancer screening with both human papillomavirus and papanicolaou testing vs papanicolaou testing alone: what screening intervals are physicians recommending? Arch Intern Med 170(11):977\u2013986","journal-title":"Arch Intern Med"},{"issue":"9","key":"976_CR32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.7326\/0003-4819-151-9-200911030-00005","volume":"151","author":"KR Yabroff","year":"2009","unstructured":"Yabroff KR, Saraiya M, Meissner HI, Haggstrom DA, Wideroff L, Yuan G, Berkowitz Z, Davis WW, Benard VB, Coughlin SS (2009) Specialty differences in primary care physician reports of papanicolaou test screening practices: a National Survey, 2006 to 2007. Ann Intern Med 151(9):602\u2013611","journal-title":"Ann Intern Med"},{"issue":"8","key":"976_CR33","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1089\/jwh.2005.14.670","volume":"14","author":"CP Cooper","year":"2005","unstructured":"Cooper CP, Saraiya M, Mclean TA, Hannan J, Liesmann JM, Rose SW, Lawson HW (2005) Report from the CDC. Pap Test Intervals Used by Physicians Serving Low-Income Women through the National Breast and Cervical Cancer Early Detection Program. J Womens Health 14(8):670\u2013678","journal-title":"J Womens Health"},{"issue":"6","key":"976_CR34","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1097\/AOG.0b013e3181fae4ca","volume":"116","author":"Z Berkowitz","year":"2010","unstructured":"Berkowitz Z, Saraiya M, Benard V, Yabroff KR (2010) Common abnormal results of pap and human papillomavirus cotesting: what physicians are recommending for management. Obstetrics Gynecol 116(6):1332\u20131340. \n                    https:\/\/doi.org\/10.1097\/AOG.1330b1013e3181fae1334ca","journal-title":"Obstetrics Gynecol"},{"issue":"3","key":"976_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/MLR.0b013e3181ca4015","volume":"48","author":"HI Meissner","year":"2010","unstructured":"Meissner HI, Tiro JA, Yabroff KR, Haggstrom DA, Coughlin SS (2010) Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals. Med Care 48(3):249\u2013259","journal-title":"Med Care"},{"issue":"1","key":"976_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/AOG.0b013e3182210034","volume":"118","author":"JW-Y Lee","year":"2011","unstructured":"Lee JW-Y, Berkowitz Z, Saraiya M (2011) Low-Risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among U.S. Health Care Providers. Obstetrics Gynecol 118(1):4\u201313","journal-title":"Obstetrics Gynecol"},{"key":"976_CR37","unstructured":"FDA approves first human papillomavirus test for primary cervical cancer screening [\n                    http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm394773.htm]"},{"key":"976_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000669","author":"WK Huh","year":"2015","unstructured":"Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FAR, Kinney WK, Massad LS, Mayeaux EJ, Saslow D et al (2015) Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstetr Gynecol. \n                    https:\/\/doi.org\/10.1097\/AOG.0000000000000669","journal-title":"Obstetr Gynecol"},{"key":"976_CR39","unstructured":"Chronological History of ACS Recommendations for the Early Detection of Cancer in People Without Cancer Symptoms [\n                    http:\/\/www.cancer.org\/healthy\/findcancerearly\/cancerscreeningguidelines\/chronological-history-of-acs-recommendations]"},{"issue":"1","key":"976_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0020-7292(02)90092-5","volume":"78","author":"ACOG","year":"2002","unstructured":"ACOG (2002) ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas. Number 35., May 2002. Int J Gynaecol Obstet 78(1):79\u201391","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"976_CR41","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1309\/6GBF-EGH8-WXDE-ANGX","volume":"118","author":"DD Davey","year":"2002","unstructured":"Davey DD, Austin RM, Birdsong G, Buck HW, Cox JT, Darragh TM, Elgert PA, Hanson V, Henry MR, Waldman J (2002) ASCCP patient management guidelines: Pap Test specimen adequacy and quality indicators. Am J Clin Pathol 118(5):714\u2013718","journal-title":"Am J Clin Pathol"},{"key":"976_CR42","volume-title":"Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force","author":"USPSTF","year":"1996","unstructured":"USPSTF (1996) Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force. 2nd\u00a0edn. WIlliams & WIlkins, Baltimore","edition":"2"},{"issue":"8","key":"976_CR43","first-page":"1759","volume":"67","author":"USPSTF: U.S. Preventive Services Task Force","year":"2003","unstructured":"USPSTF: U.S. Preventive Services Task Force (2003) Recommendations and rationale-screening for cervical cancer: recommendations and rationale. Am Fam Phys 67(8):1759\u20131766","journal-title":"Am Fam Phys"},{"issue":"6","key":"976_CR44","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/AOG.0b013e3181c6f8a4","volume":"114","author":"ACOG Practice Bulletin no. 109","year":"2009","unstructured":"ACOG Practice Bulletin no. 109 (2009) Cervical cytology screening. Obstet Gynecol 114(6):1409\u20131420","journal-title":"Obstet Gynecol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-017-0976-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0976-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0976-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T20:17:29Z","timestamp":1589660249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-017-0976-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["976"],"URL":"https:\/\/doi.org\/10.1007\/s10552-017-0976-x","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]},"assertion":[{"value":"13 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}